Jun 21, 2024
Josh Gottheimer- Amount
- $1,001 to $15,000
- Filed
- Jul 9, 2024
Congress ticker disclosure profile
As of August 1 at 7:12 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference SBGSY. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
5
Disclosed ranges
$164K
Most active member desks
6 buys vs 5 sells
Latest trade Jun 21, 2024
Jun 21, 2024
Josh GottheimerDec 5, 2023
Josh GottheimerJul 10, 2023
Daniel GoldmanFeb 17, 2021
Peter MeijerJan 28, 2021
Peter MeijerApr 16, 2020
Greg GianforteApr 14, 2020
Josh GottheimerJan 14, 2020
Greg GianforteNov 27, 2019
Josh GottheimerOct 12, 2019
Greg GianforteJan 27, 2015
Thomas Macarthur| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jun 21, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Jul 9, 2024 | Open card |
| Dec 5, 2023 | Josh Gottheimer | Sell | $1,001 to $15,000 | Jan 7, 2024 | Open card |
| Jul 10, 2023 | Daniel Goldman | Sell | $15,001 to $50,000 | Aug 13, 2023 | Open card |
| Feb 17, 2021 | Peter Meijer | Sell | $15,001 to $50,000 | Mar 16, 2021 | Open card |
| Jan 28, 2021 | Peter Meijer | Buy | $1,001 to $15,000 | Feb 23, 2021 | Open card |
| Apr 16, 2020 | Greg Gianforte | Buy | $50,001 to $100,000 | Apr 23, 2020 | Open card |
| Apr 14, 2020 | Josh Gottheimer | Buy | Receipt pending ingestion | May 13, 2020 | Open card |
| Jan 14, 2020 | Greg Gianforte | Buy | Receipt pending ingestion | Feb 14, 2020 | Receipt pending ingestion |
| Nov 27, 2019 | Josh Gottheimer | Buy | Receipt pending ingestion | Dec 9, 2019 | Open card |
| Oct 12, 2019 | Greg Gianforte | Buy | Receipt pending ingestion | Dec 23, 2019 | Open card |
| Jan 27, 2015 | Thomas Macarthur | Sell | Receipt pending ingestion | Mar 5, 2015 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 6 of 11 filed rows include disclosed amount ranges (55%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.